Australian vaccine preventable disease epidemiological review series: diphtheria 1999–2019
DOI:
https://doi.org/10.33321/cdi.2022.46.42Abstract
Background
Diphtheria is rare in Australia, but an increasing number of cases have been notified in recent years. Alongside notifications from 1999 to 2019, we analysed other relevant national data sources to evaluate trends over the past two decades.
Methods
Diphtheria notifications (National Notifiable Diseases Surveillance System [NNDSS]), hospitalisations (National Hospital Morbidity Database [NHMD]) and deaths (Australian Bureau of Statistics and the Australian Coordinating Registry) were separately analysed by site of infection, age group, sex, state/territory, Aboriginal and Torres Strait Islander status, and vaccination status.
Results
During the study period, eight (0.002 per 100,000 population per year) cases of respiratory diphtheria and 38 (0.008 per 100,000 population per year) cases of cutaneous diphtheria were recorded in the NNDSS, with 45/46 reported in the nine years since 2011. Corynebacterium diphtheriae accounted for 87% of notified cases, who had a median age of 31.5 years (respiratory diphtheria) and 52.5 years (cutaneous diphtheria); no respiratory diphtheria was notified in those under 15 years of age. A majority of the cutaneous diphtheria cases (27/38; 71%) were acquired overseas, as were 3/8 (38%) of the respiratory diphtheria cases. Rates of both presentation types were higher in Aboriginal and Torres Strait Islander people (respiratory: 0.007 per 100,000 population per year; cutaneous: 0.021 per 100,000 population per year) than were rates in the overall population. Queensland had the highest rate of notified respiratory cases (0.007 per 100,000 population per year), and the Northern Territory the highest rate of cutaneous notifications (0.043 per 100,000 population per year). There were 29 hospitalisations with a principal-diagnosis diphtheria code in the NHMD between 2002 and 2018, of which eight were designated as respiratory (0.002 per 100,000 population per year), eight as cutaneous (0.002 per 100,000 population per year), and 13 with an unknown site of infection. Among notified cases, two deaths were reported in unvaccinated people in Queensland.
Conclusions
Although diphtheria remains rare in Australia, 45 cases were notified in the years 2011–2019, compared with one case between 1999 and 2010. Robust surveillance remains important to detect all cases. High immunity will need to be maintained across all age groups to prevent outbreaks, and travel and adult booster doses should be encouraged.
Downloads
References
Galazka AM, Robertson SE, Oblapenko GP. Resurgence of diphtheria. Eur J Epidemiol. 1995;11(1):95–105. doi: https://doi.org/10.1007/BF01719954.
Dureab F, Müller O, Jahn A. Resurgence of diphtheria in Yemen due to population movement. J Travel Med. 2018;25(1). doi: https://doi.org/10.1093/jtm/tay094.
Clarke KEN, MacNeil A, Hadler S, Scott C, Tiwari TSP, Cherian T. Global epidemiology of diphtheria, 2000–2017. Emerg Infect Dis. 2019;25(10):1834–42. doi: https://doi.org/10.3201/eid2510.190271.
Polonsky JA, Ivey M, Mazhar MKA, Rahman Z, le Polain de Waroux O, Karo B et al. Epidemiological, clinical, and public health response characteristics of a large outbreak of diphtheria among the Rohingya population in Cox’s Bazar, Bangladesh, 2017 to 2019: a retrospective study. PLoS Med. 2021;18(4):e1003587. doi: https://doi.org/10.1371/journal.pmed.1003587.
Badell E, Alharazi A, Criscuolo A, Almoayed KAA, Lefrancq N, Bouchez V et al. Ongoing diphtheria outbreak in Yemen: a cross-sectional and genomic epidemiology study. Lancet Microbe. 2021. doi: https://doi.org/10.1016/S2666-5247(21)00094-X.
Truelove SA, Keegan LT, Moss WJ, Chaisson LH, Macher E, Azman AS et al. Clinical and epidemiological aspects of diphtheria: a systematic review and pooled analysis. Clin Infect Dis. 2020;71(1):89–97. doi: https://doi.org/10.1093/cid/ciz808.
Bonmarin I, Guiso N, Le Flèche-Matéos A, Patey O, Patrick AD, Levy-Bruhl D. Diphtheria: a zoonotic disease in France? Vaccine. 2009;27(31):4196–200. doi: https://doi.org/10.1016/j.vaccine.2009.04.048.
Diphtheria Guidelines Working Group. Public health control and management of diphtheria (in England and Wales): 2015 Guidelines. London: United Kingdom Government, Public Health England; March 2015. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/774753/Diphtheria_Guidelines_Final.pdf.
Hadfield TL, McEvoy P, Polotsky Y, Tzinserling VA, Yakovlev AA. The pathology of diphtheria. J Infect Dis. 2000;181(Suppl 1):S116–20. doi: https://doi.org/10.1086/315551.
Dittmann S, Wharton M, Vitek C, Ciotti M, Galazka A, Guichard S et al. Successful control of epidemic diphtheria in the states of the former Union of Soviet Socialist Republics: lessons learned. J Infect Dis. 2000;181(Suppl 1):S10–22. doi: https://doi.org/10.1086/315534.
Wagner KS, White JM, Crowcroft NS, De Martin S, Mann G, Efstratiou A. Diphtheria in the United Kingdom, 1986-2008: the increasing role of Corynebacterium ulcerans. Epidemiol Infect. 2010;138(11):1519–30. doi: https://doi.org/10.1017/S0950268810001895.
de Benoist AC, White JM, Efstratiou A, Kelly C, Mann G, Nazareth B et al. Imported cutaneous diphtheria, United Kingdom. Emerg Infect Dis. 2004;10(3):511–3.
Gower CM, Scobie A, Fry NK, Litt DJ, Cameron JC, Chand MA et al. The changing epidemiology of diphtheria in the United Kingdom, 2009 to 2017. Euro Surveill. 2020;25(11):1900462. doi: https://doi.org/10.2807/1560-7917.ES.2020.25.11.1900462.
Sharma NC, Efstratiou A, Mokrousov I, Mutreja A, Das B, Ramamurthy T. Diphtheria. Nat Rev Dis Primers. 2019;5(1):81. doi: https://doi.org/10.1038/s41572-019-0131-y.
National Centre for Immunisation Research and Surveillance (NCIRS). Significant events in diphtheria, tetanus and pertussis vaccination practice in Australia. Sydney: NCIRS; July 2019. Available from: http://ncirs.org.au/sites/default/files/2019-07/Diphtheria-tetanus-pertussis-history-July-2019.pdf.
Gidding HF, Burgess MA, Gilbert GL. Diphtheria in Australia, recent trends and future prevention strategies. Commun Dis Intell. 2000;24(6):165–7.
Dey A, Wang H, Beard F, Macartney K, McIntyre P. Summary of national surveillance data on vaccine preventable diseases in Australia, 2012–2015. Commun Dis Intell (2018). 2019;43. doi: https://doi.org/10.33321/cdi.2019.43.58.
Australian Government Department of Health. Introduction to the National Notifiable Diseases Surveillance System. [Internet.] Canberra: Australian Government Department of Health; 9 June 2015. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-nndssintro.htm.
Queensland Health. Vaccine preventable and invasive diseases in Queensland: 1 Jan – 31 Dec 2018. Brisbane: Queensland Government, Queensland Health; 2019. Available from https://www.health.qld.gov.au/__data/assets/pdf_file/0024/832443/vpd-quarterly-surveillance-2018.pdf.
Brotherton J, McIntyre P, Puech M, Wang H, Gidding H, Hull B et al. Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002. Commun Dis Intell Q Rep. 2004;28(Suppl 2):vii–S116.
Hull B, Hendry A, Dey A, Macartney K, Beard F. Immunisation coverage annual report 2019. Commun Dis Intell (2018). 2021;45. doi: https://doi.org/10.33321/cdi.2020.45.18.
Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-van Spaendonck MA et al. The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect. 2000;125(1):113–25. doi: https://doi.org/10.1017/s0950268899004161.
McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med. 2002;136(9):660–6. doi: https://doi.org/10.7326/0003-4819-136-9-200205070-00008.
Gidding HF, Backhouse JL, Burgess MA, Gilbert GL. Immunity to diphtheria and tetanus in Australia: a national serosurvey. Med J Aust. 2005;183(6):301–4. doi: https://doi.org/10.5694/j.1326-5377.2005.tb07059.x.
Lu X, Quinn HE, Menzies RI, Hueston L, Gilbert L, McIntyre PB. Diphtheria immunity in Australia: should we be concerned? Infect Disord Drug Targets. 2020;20(3):323–9. doi: https://doi.org/10.2174/1871526518666181011114834.
Australian Immunisation Handbook. Diphtheria. [Internet.] Canberra: Australian Government Department of Health; 23 April 2019. [Accessed on 27 June 2019.] Available from: https://immunisationhandbook.health.gov.au/vaccine-preventable-diseases/diphtheria.
Australian Bureau of Statistics. Childrens immunisation survey, Australia, November 1983. Canberra: Australia Bureau of Statistics; 1984. Available from https://catalogue.nla.gov.au/Record/1620836.
Australia Bureau of Statistics. Australian health survey, 1977–78. Sabin and triple antigen vaccination (persons aged 2 to 5 years). Canberra: Australian Bureau of Statistics; 1980. Available from https://catalogue.nla.gov.au/Record/66427.
Lim KH, Boon M. Cutaneous diphtheria in a returned traveller. J Paediatr Child Health. 2019;55(3):358–61. doi: https://doi.org/10.1111/jpc.14245.
Tiwari TSP, Wharton M. 19 – Diphtheria toxoid. In Plotkin SA, Orenstein WA, Offit PA, Edwards KM, eds. Plotkin’s Vaccines (7th edition). Amsterdam: Elsevier, 2018;261–75.e7. Available from: http://www.sciencedirect.com/science/article/pii/B9780323357616000195.
Gordon CL, Fagan P, Hennessy J, Baird R. Characterization of Corynebacterium diphtheriae isolates from infected skin lesions in the Northern Territory of Australia. J Clin Microbiol. 2011;49(11):3960–2. doi: https://doi.org/10.1128/JCM.05038-11.
Mishra B, Dignan RJ, Hughes CF, Hendel N. Corynebacterium diphtheriae endocarditis—surgery for some but not all! Asian Cardiovasc Thorac Ann. 2005;13(2):119–26. doi: https://doi.org/10.1177/021849230501300205.
Hoskisson PA. Microbe Profile: Corynebacterium diphtheriae – an old foe always ready to seize opportunity. Microbiology (Reading). 2018;164(6):865–7. doi: https://doi.org/10.1099/mic.0.000627.
Martini H, Soetens O, Litt D, Fry NK, Detemmerman L, Wybo I et al. Diphtheria in Belgium: 2010-2017. J Med Microbiol. 2019;68(10):1517–25. doi: https://doi.org/10.1099/jmm.0.001039.
Both L, Collins S, de Zoysa A, White J, Mandal S, Efstratiou A. Molecular and epidemiological review of toxigenic diphtheria infections in England between 2007 and 2013. J Clin Microbiol. 2015;53(2):567–72. doi: https://doi.org/10.1128/JCM.03398-14.
Otsuji K, Fukuda K, Ogawa M, Saito M. Mutation and diversity of diphtheria toxin in Corynebacterium ulcerans. Emerg Infect Dis. 2019;25(11):2122–3. doi: https://doi.org/10.3201/eid2511.181455.
NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2011: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell Q Rep. 2013;37(4):E313–93.
Dey A, Knox S, Wang H, Beard FH, McIntyre PB. Summary of national surveillance data on vaccine preventable diseases in Australia, 2008-2011. Commun Dis Intell Q Rep. 2016;40(Suppl):S1–70.
Tiwari TSP, Acosta A. Diphtheria. [Internet.] Atlanta: Centers for Disease Control and Prevention; 2019. [Accessed on 7 March 2022.] Available from: https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/diphtheria.
Queensland Health. Diphtheria: Queensland Health Guidelines for Public Health Units. [Internet.] Brisbane: Queensland Government, Queensland Health; June 2019. [Accessed on 7 March 2022.] Available from: https://www.health.qld.gov.au/cdcg/index/diphtheria.
Chiu C, Dey A, Wang H, Menzies R, Deeks S, Mahajan D et al. Vaccine preventable diseases in Australia, 2005 to 2007. Commun Dis Intell Q Rep. 2010;34(Supp):S1–167.
Menzies R, Turnour C, Chiu C, McIntyre P. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Commun Dis Intell Q Rep. 2008;32(Suppl):S2–67.
Australian Government Department of Health. Revised surveillance case definitions: Chlamydia; diphtheria; hepatitis E; pertussis. Commun Dis Intell Q Rep. 2013;37(2):E189–92.
Australian Government Department of Health. Diphtheria case definition. [Internet.] Canberra: Australian Government Department of Health; 17 January 2017. [Accessed on 11 June 2019.] Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_dipth.htm.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
